HS is a neutrophilic autoinflammatory and immune-mediated skin disease, and recent studies have identified cytokines, such as IL-17A/F and members of the IL-1 family, as key factors in its pathogenesis, particularly with the use of biologic agents [6,7]. This evidence concerns the gene IL17A and histiocytic sarcoma.